You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.
You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ, USA.
We are a leading facility for the development, testing and manufacturing of new biologics and vaccines
A number of new roles are being created in Brinny as a result of increased global demand for MSD medicines and vaccines which will also see the site further expand its production facilities and capacity to meet this demand.
Get motivated by the work that we do at MSD Brinny
The MSD site Brinny, Co. Cork is one of the region’s largest employers and has been a vibrant part of the pharmaceutical sector in Cork for over 35 years. With a strong legacy in the biopharmaceutical sector, Brinny is now specialising in the development and manufacture of innovative vaccines.
Discover a path of inventiveness and meaningful challenges
The Brinny site has been a vibrant part of the local Innishannon community for nearly 35 years and is now one of the region’s largest employers.
Get inspired by our team and find a new stimulating career with us
Explore our other sites
Opened in 1976 and currently employs 500 highly skilled people. The site has API and Formulation facilities for the manufacture and the development of new products. Work relating to 20 of MSD’s pipeline products is undertaken at this state-of-the-art research and commercialisation facility.
Opened in 2008 as MSD’s first vaccines facility outside of the US. Carlow is the filling site for the liquid form of our immuno-oncology treatment for the global market. We are currently working on the construction of a second manufacturing facility that will focus on the production of vaccines and biologics.
The base for our Animal Health and Human Health businesses as well as a number of global and national support services including Clinical Research, Medical Affairs, Regulatory Affairs, Sales, Policy & Communications and Marketing.
This site will play a pivotal role in the manufacture of MSD’s biologics-based medicines, including in the area of immuno-oncology, and will expand MSD’s current internal network of biologics drug substance manufacturing plants when full manufacturing operations begin in 2021.
The latest addition to the MSD, Ireland family is Dunboyne which joined our network in September 2020. With a team of over 200, this site will be MSD’s first Biologics Drug Substance single use commercialization facility, playing an important role in helping us commercialise key medicines.
This careers website is intended for Residents of Europe, Middle East, Africa, Latin America & Asia Pacific. Residents in the United States, Canada & Puerto Rico, please visit this Careers website. Information on this site is for the purpose of presenting career opportunities at our organisation and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, proudly embracing diversity in all of its manifestations.